Episode Details
Back to Episodes
FDA Approves mRNA Flu Shot for Seniors | Charlotte News
Description
The FDA just approved a groundbreaking new flu vaccine called mFlusiva, made with mRNA tech from the COVID-19 vaccines, specifically for adults 50 and older. While traditional flu shots are already available, this one offers faster production and could be a game-changer as flu strains evolve. Minor side effects like soreness or fatigue were reported more often than with older vaccines, but no major safety concerns emerged. The approval followed a brief regulatory pause and a strong endorsement from an FDA advisory panel — giving seniors and high-risk groups another powerful tool to stay ahead of the flu.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/635e5fbc248a4358